Browse by Poster Presenter

Skip to main content

2023 IKCS: Europe Main banner

Tweets by 2023 IKCS: Europe

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

T
Teixeira, Marcus

1. Department of Cancer Medicine, Gustave Roussy, Paris Saclay University, Villejuif, France
7: Circulating B cells subpopulations and outcomes to Checkpoint Blockade in patients with renal cell carcinoma.
Marcus Teixeira
Favorite
Toms, Charlotte

Barts ECMC, Barts Cancer Institute, Queen Mary University London
18: Optimal Duration of Frontline Immunotherapy in Patients with Metastatic Renal Cell Carcinoma (mRCC)
Charlotte Toms
Favorite
TRIPATHI, NIKITA

Mayo Clinic , Phoenix, Arizona
31: Efficacy of immune checkpoint inhibitor (ICI) combination therapy as first-line (1L) treatment in metastatic renal cell carcinoma (mRCC).
NIKITA TRIPATHI
Favorite